Andrew Reardon

Insider Reports History

Entity
Individual
Location
C/O Ligand Pharmaceuticals Incorporated, 3911 Sorrento Valley Blvd, Suite 110, San Diego, CA
Signature
/s/ Andrew Reardon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Reardon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LIGAND PHARMACEUTICALS INC CLO & Secretary Common Stock 22.5K $2.4M $106.39 Aug 28, 2024 Direct
LIGAND PHARMACEUTICALS INC CLO & Secretary Non-Qualified Stock Option (right to buy) 62.9K May 9, 2024 Direct
LIGAND PHARMACEUTICALS INC CLO & Secretary Non-Qualified Stock Option (right to buy) 61.4K Aug 28, 2024 Direct

Insider Reports Filed by Andrew Reardon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LGND LIGAND PHARMACEUTICALS INC Aug 28, 2024 3 -$81.2K 4 Aug 30, 2024 CLO & Secretary
LGND LIGAND PHARMACEUTICALS INC Jun 28, 2024 1 $20K 4 Jul 2, 2024 Chief Legal Officer &
LGND LIGAND PHARMACEUTICALS INC May 9, 2024 3 -$308K 4 May 13, 2024 Chief Legal Officer &
LGND LIGAND PHARMACEUTICALS INC Feb 27, 2024 2 $0 4 Feb 29, 2024 CHIEF LEGAL OFFICER &
LGND LIGAND PHARMACEUTICALS INC Feb 15, 2024 1 -$44.3K 4 Feb 16, 2024 CHIEF LEGAL OFFICER &
LGND LIGAND PHARMACEUTICALS INC Dec 29, 2023 1 $10.9K 4 Jan 4, 2024 CHIEF LEGAL OFFICER &
LGND LIGAND PHARMACEUTICALS INC Aug 10, 2023 1 -$61.7K 4 Aug 14, 2023 CHIEF LEGAL OFFICER &
LGND LIGAND PHARMACEUTICALS INC Mar 24, 2023 1 -$21K 4 Mar 28, 2023 Chief Legal Officer and Secretary
LGND LIGAND PHARMACEUTICALS INC Feb 23, 2023 2 $0 4 Feb 27, 2023 Chief Legal Officer and Secretary
LGND LIGAND PHARMACEUTICALS INC Nov 30, 2022 1 -$78.2K 4 Dec 1, 2022 Chief Legal Officer and Secretary
LGND LIGAND PHARMACEUTICALS INC Nov 1, 2022 0 $0 3 Nov 7, 2022 Chief Legal Officer and Secretary Exhibit 24 - Power of Attorney.